Completed NA INTERVENTIONAL 2-arm NCT02721368

Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume

Clinical Study of Neuramis® Volume Lidocaine to Evaluate the Efficacy and Safety for Temporary Restoring the Mid-face Volume

Sponsor: Medy-Tox

Conditions Aging

Interventions Juvederm® Voluma® with Lidocaine Neuramis® Volume Lidocaine

Updated 10 times since 2017 Last updated: Oct 12, 2020 Started: Nov 3, 2016 Primary completion: Oct 31, 2017 Completion: Sep 11, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02721368, this NA trial focuses on Aging and remains completed. Sponsored by Medy-Tox, it has been updated 10 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2020 — Jan 2021 [monthly]

Completed NA

▶ Show 5 earlier versions

Sep 2020 — Nov 2020 [monthly]

Completed NA
Feb 2019 — Sep 2020 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE3 → NA
Jun 2018 — Feb 2019 [monthly]

Unknown Status PHASE3
Apr 2018 — Jun 2018 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status
Jan 2017 — Apr 2018 [monthly]

Active Not Recruiting PHASE3

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medy-Tox

Data source: Medy-Tox

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea